GO:0070778 L-aspartate transmembrane transport: Transport Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070778 (L-aspartate transmembrane transport) describes the directed movement of L-aspartate across a membrane by a transporter or pore.
• L-aspartate transport is mediated by dedicated carriers such as the aspartate:alanine antiporter AspT in bacteria and by excitatory amino acid transporters in mammalian systems.
• The process is essential for amino acid uptake, neurotransmitter recycling, and metabolic balance in both prokaryotes and eukaryotes.
• Key molecular determinants include transmembrane helix residues such as R76 in AspT, which is required for substrate transport.
• Defects in aspartate transport and related membrane transport proteins are linked to neurological and metabolic disorders, including Alzheimer's disease-related trafficking defects.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise interrogation of L-aspartate transport genes in disease and physiology.
Description
L-aspartate transmembrane transport (GO:0070778) is the directed movement of the amino acid L-aspartate across a biological membrane by means of a transporter or pore. This process is fundamental to amino acid homeostasis, nitrogen metabolism, and intercellular signaling in organisms ranging from bacteria to mammals. In bacteria, L-aspartate transport supports energy metabolism and substrate uptake, as shown for the photosynthetic bacterium Chromatium vinosum. In mammals, aspartate transport is critical for neurotransmitter cycling and synaptic function, with synaptosomal preparations from rat brain demonstrating high-affinity aspartate uptake. Researchers study GO:0070778 to understand membrane transport mechanisms, to identify transporter residues that govern substrate specificity, and to link transport dysfunction to human disease. The term is also relevant to cobalamin transport and intracellular trafficking pathways, where related transmembrane helices and transporters are indispensable. Because L-aspartate is a key metabolite and signaling molecule, its transport is a focal point for genetics, biochemistry, and drug discovery.
L-aspartate transmembrane transport At A Glance
| GO ID | GO:0070778 |
|---|---|
| GO term | L-aspartate transmembrane transport |
| Ontology | biological_process |
| Synonym | L-aspartate transport |
| Major function | Directed movement of L-aspartate across a membrane via a transporter or pore |
| Example transporter | Aspartate:alanine antiporter AspT (bacterial) |
| Key residue | R76 in transmembrane domain 3 of AspT is involved in substrate transport |
| Related transport system | ABCD4 transmembrane helix 6 is indispensable for cobalamin transport |
| Physiological context | Aspartate uptake in synaptosomes and photosynthetic bacteria |
What Is GO:0070778?
According to the Gene Ontology, GO:0070778 (L-aspartate transmembrane transport) is defined as the directed movement of L-aspartate across a membrane by means of some agent such as a transporter or a pore. In other words, it covers any protein-mediated process that moves L-aspartate from one side of a lipid bilayer to the other, including antiport, symport, and channel-like mechanisms.
Why Is L-aspartate transmembrane transport Important in Cell Biology?
L-aspartate transmembrane transport is important because it controls the availability of a central amino acid for protein synthesis, neurotransmission, and energy metabolism. In bacteria, aspartate transport supports substrate utilization and metabolic adaptation. In mammals, it contributes to synaptic aspartate clearance and recycling, which is essential for normal brain function. Moreover, transport proteins and their transmembrane domains are increasingly recognized as drug targets and as contributors to disease when mutated or misregulated.
• Maintains intracellular and extracellular L-aspartate pools for metabolism and signaling.
• Supports neurotransmitter recycling and synaptic function in the mammalian brain.
• Enables bacterial energy metabolism and substrate uptake in photosynthetic bacteria.
• Provides a model system for studying antiporter mechanism and substrate specificity.
• Links to cobalamin transport through shared transmembrane transport principles.
• Relevant to Alzheimer's disease through protein trafficking and membrane transport defects.
• Informs drug design targeting amino acid transporters and antiporters.
• Helps interpret genetic variants in transport proteins associated with metabolic disease.
• Guides CRISPR-based functional studies of transporter residues and domains.
• Connects to polyamine transport and broader nitrogenous compound transport in microbes.
What Happens During L-aspartate transmembrane transport?
Substrate recognition and binding
In simple terms: The transporter first grabs L-aspartate from one side of the membrane.
Transport begins when a membrane protein recognizes L-aspartate and binds it with sufficient affinity to discriminate it from related amino acids. In the aspartate:alanine antiporter AspT, substrate binding triggers conformational changes that are essential for transport. Specific residues, such as R76 in transmembrane domain 3, are involved in substrate transport, indicating that binding and subsequent movement are tightly coupled to the protein structure.
Conformational transition of the transporter
In simple terms: The transporter changes shape to move the amino acid across the membrane.
After binding, the transporter undergoes a conformational transition that exposes the substrate to the opposite side of the membrane. L-Ala binding to the aspartate:alanine antiporter induces a conformational transition, as shown by structural and biochemical studies. This alternating-access mechanism is a hallmark of many secondary transporters and is required for the directed movement of L-aspartate.
Translocation across the lipid bilayer
In simple terms: The amino acid is carried through the membrane barrier.
The actual translocation step moves L-aspartate across the hydrophobic core of the membrane. In bacteria such as Chromatium vinosum, L-aspartate transport has been characterized as a specific uptake process. In mammalian synaptosomes, aspartate transport is similarly mediated by membrane proteins that facilitate movement across the plasma membrane. The process requires a continuous pathway or a series of conformational states that shield the charged amino acid from the lipid bilayer.
Release and resetting of the transporter
In simple terms: The amino acid is released on the other side, and the transporter resets for another round.
Once L-aspartate is released on the trans side of the membrane, the transporter returns to its initial conformation to complete the cycle. This resetting step is essential for continuous transport and is influenced by the same structural elements that mediate binding and translocation. Related transport systems, such as those involved in cobalamin transport, also depend on specific transmembrane helices for function, underscoring the importance of protein architecture in transport cycles.
Integration with cellular metabolism and signaling
In simple terms: Once inside, aspartate feeds into metabolism and signaling pathways.
Transported L-aspartate enters metabolic and signaling networks. In bacteria, it can serve as a carbon and nitrogen source. In the nervous system, aspartate transport contributes to neurotransmitter homeostasis and synaptic activity. Broader transport processes, including polyamine transport in bacteria and yeast, illustrate how amino acid and amine transport systems are integrated into cellular physiology. Defects in membrane trafficking can also impact transport protein localization, as seen in Alzheimer's disease-related trafficking studies.
Key Genes Involved in GO:0070778 L-aspartate transmembrane transport
The following genes and proteins are directly or functionally linked to L-aspartate transmembrane transport and related membrane transport processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| aspT (AspT) | Aspartate:alanine antiporter that transports L-aspartate and L-alanine | Model for antiporter mechanism and substrate specificity |
| ABCD4 | Transmembrane transporter with helix 6 indispensable for cobalamin transport | Illustrates transmembrane helix requirements in transport |
| SPP/SPPL proteases | Intramembrane proteases affecting membrane protein function | Linked to transport protein processing and trafficking |
| EAATs (SLC1A family) | Excitatory amino acid transporters including aspartate transport | Key to neurotransmitter recycling |
| SLC1A1 | Neuronal glutamate/aspartate transporter | Synaptic aspartate clearance |
| SLC1A2 | Glial glutamate/aspartate transporter | Astrocytic aspartate uptake |
| SLC1A3 | Glutamate/aspartate transporter | Synaptic homeostasis |
| SLC1A6 | Excitatory amino acid transporter | Retinal and neuronal aspartate transport |
| SLC1A7 | Excitatory amino acid transporter | Retinal aspartate transport |
| SLC25A12 | Mitochondrial aspartate/glutamate carrier | Metabolic aspartate shuttling |
| SLC25A13 | Mitochondrial aspartate/glutamate carrier | Urea cycle and metabolism |
| GOT1 | Aspartate aminotransferase | Aspartate metabolism downstream of transport |
| GOT2 | Mitochondrial aspartate aminotransferase | Aspartate metabolism |
| ASNS | Asparagine synthetase | Aspartate utilization |
| ASS1 | Argininosuccinate synthase | Aspartate consumption in urea cycle |
| CAD | Carbamoyl-phosphate synthetase 2 | Aspartate usage in pyrimidine synthesis |
| PPAT | Phosphoribosyl pyrophosphate amidotransferase | Aspartate in purine synthesis |
How Is L-aspartate transmembrane transport Regulated?
L-aspartate transmembrane transport is regulated at multiple levels. Transporter activity can be modulated by substrate availability and by conformational transitions induced by binding of related amino acids such as L-alanine. Specific residues, including R76 in transmembrane domain 3 of AspT, are required for transport, and mutations in these positions alter function. In mammalian systems, transport is influenced by membrane trafficking and protein localization, as defects in trafficking pathways can affect transporter function and are linked to Alzheimer's disease. Related transport systems, such as cobalamin transport via ABCD4, depend on specific transmembrane helices, highlighting the importance of protein structure in regulation. Intramembrane proteases such as SPP/SPPL can also influence membrane protein function and processing, indirectly affecting transport.
L-aspartate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC1A1 | Neurological dysfunction and synaptic aspartate imbalance | Knockout mouse or neuronal cell line |
| SLC1A2 | Excitotoxicity and neurodegeneration | Point-mutation knock-in in glial cells |
| ABCD4 | Cobalamin transport disorder | Knockout and rescue in patient fibroblasts |
| SPP/SPPL | Alzheimer's disease-related trafficking | Overexpression and knockout in neuronal models |
| aspT (AspT) | Bacterial transport mechanism | Point mutations at R76 in bacterial expression system |
Neurological disorders and synaptic dysfunction
L-aspartate transport is critical for neurotransmitter homeostasis in the brain. Synaptosomal studies have characterized aspartate uptake, which is essential for synaptic function. Disruptions in transport can contribute to excitotoxicity and neurological disease. Protein trafficking defects, including those relevant to Alzheimer's disease, can impair membrane protein localization and function, indirectly affecting aspartate transport systems.
Metabolic and transport disorders
Mutations in membrane transporters can cause metabolic disease. For example, ABCD4 transmembrane helix 6 is indispensable for cobalamin transport, and defects in such transport proteins lead to inherited disorders. By analogy, altered L-aspartate transport may contribute to metabolic imbalances, although direct disease associations require further study.
Cancer and cell proliferation
Aspartate is a key metabolite for nucleotide synthesis and cell proliferation. Transport of L-aspartate into cells supports biosynthetic pathways, and altered transport may influence cancer cell metabolism. However, direct evidence linking GO:0070778 to cancer remains limited, and most insights come from general amino acid transport studies.
From L-aspartate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene mediate L-aspartate transport? | CRISPR knockout in HEK293 or HeLa cells followed by uptake assay |
| Which residues are required for transport? | Point-mutation knock-in of transporter residues such as R76 |
| How does transport affect synaptic function? | Knockout of SLC1A family members in primary neurons |
| What is the role of transmembrane helix 6 in transport? | Knock-in of ABCD4 variants in patient cells |
| Can transport be restored by gene replacement? | Knock-in of wild-type transporter into knockout background |
| How does transport influence metabolism? | Overexpression of aspartate transporters in metabolic cell lines |
How to Study the L-aspartate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate and kinetics | Characterizing L-aspartate transport in cells |
| Site-directed mutagenesis | Residue requirement for transport | Identifying critical residues like R76 |
| CRISPR knockout screen | Genes required for transport | Discovering novel transporters |
| Structural biology (cryo-EM/X-ray) | Conformational states | Understanding antiporter mechanism |
| Live-cell imaging | Transporter localization | Trafficking studies in neurons |
| Proteomics | Protein interactions | Identifying transport complexes |
| Metabolic flux analysis | Aspartate utilization | Linking transport to metabolism |
| Electrophysiology | Transport currents | Functional characterization of electrogenic transporters |
Transport uptake assays
Radiolabeled or fluorescent L-aspartate uptake assays are used to measure transport activity directly. These assays have been applied in synaptosomes and bacteria to characterize aspartate transport kinetics. They are essential for validating candidate transporters identified by genetic screens.
Structural and mutational analysis
Site-directed mutagenesis combined with structural studies identifies residues critical for transport. For example, R76 in transmembrane domain 3 of AspT was shown to be involved in substrate transport. Conformational transitions induced by ligand binding can be studied by crystallography or spectroscopy.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for L-aspartate transport or sensitivity. Such screens are powerful for discovering novel transporters and regulatory factors, and can be combined with metabolic readouts.
Protein trafficking and localization studies
Because transport proteins must reach the correct membrane, trafficking studies are important. Defects in protein trafficking are linked to Alzheimer's disease and can affect transporter function. Imaging and biochemical fractionation can assess localization of transporters such as ABCD4.
How CRISPR Can Be Used to Study GO:0070778 L-aspartate transmembrane transport
Knockout
CRISPR knockout of candidate transporter genes, such as SLC1A family members or aspT, allows researchers to test whether L-aspartate transport is abolished. Knockout models are essential for establishing causality and for measuring residual transport activity.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to test specific residues. For example, mutating R76 in AspT disrupts substrate transport, providing direct evidence for its role. Similar approaches can be applied to mammalian transporters to dissect mechanism.
Knock-in
Knock-in of wild-type or mutant transporters into a knockout background enables rescue experiments and precise structure-function studies. This is particularly useful for validating disease variants in genes such as ABCD4.
Overexpression
Overexpression of L-aspartate transporters can enhance transport capacity and is used to study downstream metabolic effects. Overexpression models help link transport activity to cellular phenotypes such as proliferation or neurotransmitter release.
How EDITGENE Supports L-aspartate transmembrane transport Research
Researchers studying L-aspartate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, how specific residues contribute to function, and whether disease-associated variants alter activity. EDITGENE provides CRISPR-based cell model services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for L-aspartate transmembrane transport research.
Frequently Asked Questions About L-aspartate transmembrane transport
What is L-aspartate transmembrane transport?
It is the directed movement of L-aspartate across a membrane by a transporter or pore, defined as GO:0070778.
What genes are involved in L-aspartate transmembrane transport?
Genes include aspT in bacteria and SLC1A family members in mammals, as well as related transporters like ABCD4.
What is the function of GO:0070778?
It describes the biological process of moving L-aspartate across membranes, which is essential for metabolism and signaling.
Which residues are important for aspartate transport?
R76 in transmembrane domain 3 of the aspartate:alanine antiporter AspT is involved in substrate transport.
How is L-aspartate transport studied?
Common methods include radiolabeled uptake assays, site-directed mutagenesis, and CRISPR screens.
Is L-aspartate transport linked to disease?
Yes, defects in transport and trafficking are linked to neurological disorders such as Alzheimer's disease and metabolic transport disorders.
What is the role of aspartate transport in the brain?
It contributes to neurotransmitter homeostasis and synaptic function, as shown in synaptosomal studies.
Can CRISPR be used to study L-aspartate transport?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools for dissecting transporter function.
What is the aspartate:alanine antiporter?
AspT is a bacterial antiporter that transports L-aspartate and L-alanine and serves as a model for transport mechanism.
What are the synonyms for GO:0070778?
The synonym is L-aspartate transport.
Conclusion
GO:0070778 (L-aspartate transmembrane transport) is a fundamental biological process that governs the movement of L-aspartate across membranes in organisms from bacteria to humans. Its study provides insights into transporter mechanism, neurotransmitter homeostasis, and metabolic regulation. Dysregulation of transport and related trafficking pathways is linked to neurological and metabolic diseases, making it a compelling target for functional genomics and drug discovery. CRISPR-based models offer precise tools to interrogate the genes and residues that control this process, accelerating research and therapeutic development.
References
- 1. Suzuki S et al.. 2022. Conformational transition induced in the aspartate:alanine antiporter by L-Ala binding.. Sci Rep 12(1):15871 PMID: 36151227
- 2. Imai M et al.. 2024. Transmembrane helix 6 of ABCD4 is indispensable for cobalamin transport.. J Inherit Metab Dis 47(2):366-373 PMID: 38069516
- 3. Mentrup T et al.. 2020. Physiological functions of SPP/SPPL intramembrane proteases.. Cell Mol Life Sci 77(15):2959-2979 PMID: 32052089
- 4. Suzuki S et al.. 2016. R76 in transmembrane domain 3 of the aspartate:alanine transporter AspT is involved in substrate transport.. Biosci Biotechnol Biochem 80(4):744-7 PMID: 26849958
- 5. Cobb AD et al.. 1983. L-aspartate transport in the photosynthetic bacterium Chromatium vinosum.. Arch Biochem Biophys 225(1):86-94 PMID: 6614931
- 6. Erecińska M et al.. 1983. Aspartate transport in synaptosomes from rat brain.. J Biol Chem 258(15):9069-77 PMID: 6874678
- 7. Igarashi K et al.. 1999. Polyamine transport in bacteria and yeast.. Biochem J 344 Pt 3(Pt 3):633-42 PMID: 10585849
- 8. Uemura K et al.. 2004. Protein trafficking and Alzheimer's disease.. Curr Alzheimer Res 1(1):1-10 PMID: 15975080
